New Market Study Published: Croatia Pharmaceuticals & Healthcare Report Q3 2013
Croatia's entrance into the EU will accelerate its economic liberalisation and the development of the country's private sector. It is also likely to bring about an influx of EU funding in modernising the country's economy. The Croatian pharmaceutical market continues to pose a challenging environment to domestic and international drugmakers, but we believe EU accession will ease the regulatory burden as legislation is harmonised with EU norms. In 2013 the economy is expected to post weak growth in anticipation of...
View full press release